BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33059027)

  • 21. Long noncoding RNA DLX6-AS1 promotes renal cell carcinoma progression via miR-26a/PTEN axis.
    Zeng X; Hu Z; Ke X; Tang H; Wu B; Wei X; Liu Z
    Cell Cycle; 2017; 16(22):2212-2219. PubMed ID: 28881158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long Noncoding RNA
    Xie F; Xie G; Sun Q
    Cancer Biother Radiopharm; 2020 Mar; 35(2):129-136. PubMed ID: 32077747
    [No Abstract]   [Full Text] [Related]  

  • 23. Long non-coding RNA DLX6-AS1 silencing inhibits malignant phenotypes of gastric cancer cells.
    Fu X; Tian Y; Kuang W; Wen S; Guo W
    Exp Ther Med; 2019 Jun; 17(6):4715-4722. PubMed ID: 31105791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma.
    Li J; Li P; Zhao W; Yang R; Chen S; Bai Y; Dun S; Chen X; Du Y; Wang Y; Zang W; Zhao G; Zhang G
    Cancer Cell Int; 2015; 15():48. PubMed ID: 26052251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1.
    Wu Q; Ma J; Meng W; Hui P
    Cancer Biol Ther; 2020; 21(1):17-25. PubMed ID: 31591939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.
    Tian S; Liu J; Kong S; Peng L
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32785606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA HOXD-AS1 in cancer.
    Li L; Wang Y; Zhang X; Huang Q; Diao Y; Yin H; Liu H
    Clin Chim Acta; 2018 Dec; 487():197-201. PubMed ID: 30290157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA DLX6-AS1/miR-129-5p/DLK1 axis aggravates stemness of osteosarcoma through Wnt signaling.
    Zhang RM; Tang T; Yu HM; Yao XD
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):260-266. PubMed ID: 30442366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers.
    Hu Q; Tai S; Wang J
    Pathol Res Pract; 2019 May; 215(5):843-848. PubMed ID: 30723052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of long noncoding RNA DLX6-AS1 promotes cell growth and metastasis in esophageal squamous cell carcinoma via targeting miR-577.
    Wu SB; Wang HQ
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1195-1201. PubMed ID: 32096208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA.
    Fang C; Qiu S; Sun F; Li W; Wang Z; Yue B; Wu X; Yan D
    Cancer Lett; 2017 Dec; 410():50-62. PubMed ID: 28943452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA DLX6-AS1 promotes laryngeal squamous cell carcinoma growth and invasion through regulating miR-376c.
    Yang Q; Sun J; Ma Y; Zhao C; Song J
    Am J Transl Res; 2019; 11(11):7009-7017. PubMed ID: 31814904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133a.
    Chen B; Li Q; Zhou Y; Wang X; Zhang Q; Wang Y; Zhuang H; Jiang X; Xiong W
    Cell Cycle; 2018; 17(16):1949-1966. PubMed ID: 30300116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
    Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
    Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA
    Sun W; Zhang L; Yan R; Yang Y; Meng X
    Onco Targets Ther; 2019; 12():3945-3954. PubMed ID: 31190891
    [No Abstract]   [Full Text] [Related]  

  • 36. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.
    Zhao Z; Liang S; Sun F
    Front Oncol; 2020; 10():1172. PubMed ID: 32850336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of long non-coding RNA TP73-AS1 in cancer.
    Chen C; Shu L; Zou W
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
    Li H; Zhou Y; Cheng H; Tian J; Yang S
    Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of long non coding RNA CA3-AS1 suppresses proliferation, invasion and promotes apoptosis via miRNA-93/PTEN axis in colorectal cancer.
    Wei H; Yang Z; Lin B
    Gene; 2019 Mar; 687():9-15. PubMed ID: 30415006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.